DIGESTIVE DISEASES, published by KARGER, stands as a leading international journal dedicated to the field of gastroenterology and digestive health. With an ISSN of 0257-2753 and E-ISSN 1421-9875, the journal has been providing a platform for high-quality research since its inception in 1983, continuing to disseminate groundbreaking findings and insights through to 2024. Positioned in the second quartile (Q2) of both the gastroenterology and miscellaneous medicine categories as of 2023, DIGESTIVE DISEASES is recognized for its rigorous peer-review process and its contributions to advancing clinical and experimental gastroenterological knowledge. Its Scopus ranking at #62 out of 167 in the gastroenterology field reflects its significant impact, as it reaches a notable 63rd percentile among its peers. While it does not currently offer open access options, its subscription model ensures that vital research is available to professionals and institutions committed to the field. The journal serves as an essential resource for researchers, clinicians, and students alike who seek to deepen their understanding of digestive disorders and their implications in medicine.

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

AIMS Microbiology, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed Open Access journal dedicated to advancing the field of microbiology since its inception in 2015. With an ISSN of 2471-1888, the journal aims to disseminate high-quality research and innovative findings pertaining to both fundamental and applied microbiology, encompassing areas such as medical microbiology, immunology, and related life sciences. Recognized for its academic rigor, AIMS Microbiology has achieved a significant standing, evidenced by its current Q2 ranking in both Microbiology and Medical Microbiology categories, along with impressive percentile rankings within prestigious Scopus metrics. Based in the United States, the journal not only emphasizes accessibility and widespread dissemination of knowledge but also plays a crucial role in fostering collaboration among researchers and professionals in the microbiological sciences. By providing a platform for collaborative research and innovative ideas, AIMS Microbiology is poised to influence the future development and application of microbiological research, making it a valuable resource for students, researchers, and practitioners alike.

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Malaysian Journal of Microbiology is a prestigious open-access journal dedicated to advancing the field of microbiology, published by the Malaysian Society for Microbiology. Since its inception in 2005, this journal has become an essential platform for researchers and practitioners, facilitating the dissemination of innovative studies in applied microbiology, biotechnology, and infectious diseases. Based in Penang, Malaysia, this journal not only focuses on local microbiological research but also positions itself within the broader global scientific community. Although currently placed in the Q4 category in several relevant fields—including Applied Microbiology and Biotechnology, Infectious Diseases, and Medical Microbiology according to the 2023 Scopus rankings—it plays a crucial role in encouraging novel research and fostering collaboration among scientists. The journal encourages submissions that contribute to the understanding of microbial processes, disease mechanisms, and novel biotechnological applications, thereby supporting the continuous growth of knowledge in microbiology. With open access since its launch, the Malaysian Journal of Microbiology ensures that all published works are freely available to the public, enhancing their visibility and impact within the scientific community.

Microbiology Research, published by MDPI, stands as a pivotal open-access journal in the field of microbiology, having established its presence since 2010. Based in Switzerland, this journal strives to provide a platform for innovative research and cutting-edge findings in various branches of microbiology, including medical microbiology and molecular biology. With an impact factor that reflects its dedication to scholarly excellence, Microbiology Research is classified in the Q3 category for both microbiology and medical microbiology, and Q4 for molecular biology as of 2023, indicating its growing importance and outreach within these domains. The journal aims to foster discussion and collaboration among researchers, professionals, and students by presenting articles that cover a wide array of topics and methodologies in microbiological research. Leveraging its open-access model, Microbiology Research ensures that high-quality research is accessible to a global audience, thus facilitating the advancement of knowledge and innovation in the microbial sciences.

ANAEROBE is a highly regarded scholarly journal published by Elsevier Science Ltd, dedicated to advancing the study of anaerobic microorganisms and their roles in infectious diseases, microbiology, and various clinical applications. With an ISSN of 1075-9964 and an E-ISSN of 1095-8274, this journal has established itself as a pivotal resource for researchers and professionals interested in the unique aspects of anaerobic biology since its inception in 1995. Ranking in the Q2 category in both Infectious Diseases and Microbiology, it stands out for its commitment to publishing high-quality research that reflects the evolving complexities of microbial interactions in health and disease. Although the journal currently does not offer Open Access options, its impact is notable, with the 2023 Scopus rankings reflecting a practice of excellence—ranked #137/344 in Infectious Diseases and #96/182 in Microbiology. As a vital forum for scholarly exchange, ANAEROBE serves as an essential platform for scientists seeking to explore the depths of anaerobic studies, shaping future discoveries and clinical advancements.

Current Clinical Microbiology Reports, published by Springer, is a leading international journal dedicated to advancing the field of clinical microbiology. With a focus on the diagnosis, treatment, and prevention of infectious diseases, this journal serves as a vital resource for researchers, medical professionals, and students engaged in microbiological studies. As a testament to its quality and influence, it holds an impressive impact factor and ranks in the Q1 category in both Infectious Diseases and Microbiology (medical), reflecting its prominent standing in the scholarly community. Additionally, it features a commendable Scopus ranking, placing it in the 77th percentile for Medicine - Infectious Diseases and the 69th percentile for Medicine - Microbiology (medical). With contributions spanning over a decade, from 2014 to 2024, the journal continues to publish high-quality research articles that shape the future of clinical practices and public health policies. While access options are variable, the journal's commitment to open dialogue and dissemination of knowledge makes it a pivotal platform for those passionate about tackling microbial challenges in healthcare.

Gut Microbes, published by TAYLOR & FRANCIS INC, stands as a leading academic journal in the fields of Gastroenterology, Infectious Diseases, and Microbiology, with a distinguished Q1 ranking in all relevant categories for 2023. With an ISSN of 1949-0976 and an E-ISSN of 1949-0984, this journal has been at the forefront of microbiome research since its inception in 2010 and continues to provide an essential platform for the dissemination of groundbreaking studies and reviews related to gut microbiota and health. Researchers and professionals benefit from an impressive impact factor, underlining the journal's commitment to high-quality peer-reviewed articles that push the boundaries of our understanding of microbial interactions and their implications in various medical contexts. While it operates under a traditional subscription model, the journal ensures that its content remains accessible to the global scientific community through institutional access programs. As we look ahead to converging years until 2024, Gut Microbes remains a pivotal resource for those seeking to explore the intricate connections between the gut microbiome, health, and disease.

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.